VHL and renal carcinoma: Activation of the HIF pathway is a common final aspect of many cancers arising from a variety of events, including intratumoral hypoxia, signaling molecules (reactive oxygen species, cytokines, and growth factors) and oncogenic transformation (e.g., VHL loss of function in renal carcinoma) [86].